← FDA Drug Approvals (Drugs@FDA)

TRIUMEQ

NDA · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2014-08-22

Drug application

FDA Application #

NDA205551

Application type

New Drug Application

Brand name

TRIUMEQ

Generic name

ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE

Active ingredients

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

VIIV HLTHCARE

Manufacturer

ViiV Healthcare Company

First approval

2014-08-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown